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The self-assembly of α-synuclein (αS) into intraneuronal inclusion bodies is a key char-
acteristic of Parkinson’s disease. To define the nature of the species giving rise to neuronal
damage, we have investigated the mechanism of action of the main αS populations that have
been observed to form progressively during fibril growth. The αS fibrils release soluble
prefibrillar oligomeric species with cross-β structure and solvent-exposed hydrophobic
clusters. αS prefibrillar oligomers are efficient in crossing and permeabilize neuronal mem-
branes, causing cellular insults. Short fibrils are more neurotoxic than long fibrils due to the
higher proportion of fibrillar ends, resulting in a rapid release of oligomers. The kinetics of
released αS oligomers match the observed kinetics of toxicity in cellular systems. In addition
to previous evidence that αS fibrils can spread in different brain areas, our in vitro results
reveal that αS fibrils can also release oligomeric species responsible for an immediate dys-
function of the neurons in the vicinity of these species.
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Intracellular fibrillar inclusions of the protein α-synuclein (αS),called Lewy bodies, are characteristic of a range of neurodegen-erative disorders, collectively referred to as synucleinopathies1.
Most of the experimental evidence indicates that protein aggregation
is a gain-of-toxic-function process that plays a central role in the
pathogenesis2,3. A variety of in vitro studies is indicative of a
nucleated conformational conversion model of αS, in which the
intermediate oligomeric species are inherently transient, hetero-
geneous, and only populated at low levels during aggregation4–7.
Growing experimental evidence suggests that specific oligomeric
species are the most cytotoxic forms of αS and play a key role in
disease1,4,6,8–11. A detailed characterization of two structural types
of stable αS oligomers that were trapped using different strate-
gies was recently reported4,8. One type is largely disordered in
terms of secondary structure and the other type contains a β-sheet
rich core; we refer to these species as type-A* oligomers (OA*) and
type-B* prefibrillar oligomers (OB*), respectively8. Interestingly,
we found that while OA* are able to interact with the membrane
surface, although in an unspecific manner and with no apparent
membrane insertion and perturbation, prefibrillar OB* were found
not only to establish strong interactions with the bilayer through its
unstructured N-terminal segment (residues 1–26), but also to
insert its β-sheet core in the interior of the bilayer, causing major
membrane disruption4,8,12,13. This causes only OB* to be toxic,
whereas OA* are biologically inert8,12.
On the other hand, αS fibrils have also been reported to be
toxic and their toxicity has been associated with membrane
perturbation14–16. Evidence is also accumulating that certain αS
species transmit and induce seeding in neighboring cells in a
spreading process in which different areas of the brain are slowly
and inexorably affected17–21. Uptake of small αS fibrillar species
by neuronal cells has indeed been observed22,23 and particularly
small αS fibrils are indeed used to induce Parkinson’s disease
(PD)-like phenotypes when injected in mice brains18,23,24. In
order to have a thorough and exhaustive understanding of
pathogenesis in PD and other synucleinopathies, the effect of
fibril spreading, fibril toxicity, and oligomer toxicity have to be
considered.
Here we have established the mechanisms of membrane per-
turbation and dysfunction to neuronal cells of highly stable and
well-defined αS aggregates, such as type-B* prefibrillar oligomers
(OB*), short fibrils (SF), and long fibrils (LF) under physiological
conditions and endogenous levels of αS expression. In addition to
the well-established contribution of αS fibrils to the diffusion of
the pathology by a spreading mechanism, our results show that
the fibrillar species can have an immediate toxic effect due to the
release of toxic oligomeric species in human iPSC-derived
dopaminergic neurons, rat primary cortical neurons, and
human SH-SY5Y neuroblastoma cells. These findings reveal that
the αS species detected in neurons and SH-SY5Y cells by confocal
and stimulated emission depletion (STED) microscopy using
different probes arise from exogenous human αS derived from
SF/LF, rather than endogenous rat αS converted in oligomeric
form by a seeding process.
Results
αS fibrils interact weakly with the surface of the lipid bilayer of
synthetic membranes. All species studied in this work (OB*, SF,
LF) were first characterized for morphological, structural, and
tinctorial properties with atomic force microscopy (AFM), far-
UV circular dichroism (CD), and Fourier-transform infrared
(FT-IR) spectroscopy, X-ray diffraction, and thioflavin T
(ThT) and 8-anilinonaphthalene-1-sulfonic acid (ANS) fluores-
cence (Table S1, Figures S1, and S2a-e). We also characterized the
monomer (M) and OA* as negative controls. This allowed their
identity to be confirmed, relative to previous works, and their
properties to be studied. In brief, OA*/OB* are globular-like
aggregates with height of 4–5 nm, whereas SF and LF have
elongated morphologies with similar height but lengths differing
by one and two orders of magnitude with respect to height,
respectively. OA*/M show disordered secondary structure. SF/LF
possess similarly high degrees of β-sheet conformation, whereas
OB* species have an intermediate content. Unlike OA*/M, OB*
have a significant but weak ThT binding, whereas SF/LF have a
large ThT binding. Unlike M/OA*, OB*/SF/LF also have a strong
ANS binding, indicating a high degree of solvent-exposed
hydrophobicity.
Using paramagnetic relaxation enhancement (PRE) with magic
angle spinning (MAS) solid-state nuclear magnetic resonance
(ssNMR) spectroscopy, it was recently shown that the prefibrillar
OB* species are able to anchor to synthetic synaptic-like small
unilamellar vesicles (SUVs), through binding of the exposed N-
terminal region of αS, and then to penetrate into the bilayer with
its structured β-sheet core, causing substantial perturbations to its
structure8. In the same study it was shown that M/OA* interact
with the membrane surface, but without insertion into the lipid
bilayer8,25. In the present work, we extended such studies to the SF
and LF fibrillar species. We probed, in particular, the interaction of
the rigid cores of the SF and LF (140 µM monomer equivalents)
with SUVs with DOPE:DOPS:DOPC lipid composition (molar
ratio of 5:3:2). In these experiments, small quantities of lipid
molecules labeled with a paramagnetic center (PC), that induces
relaxation in the nucleus of nearby atoms, were incorporated into
the bilayers8,26. Unlike prefibrillar OB*, we did not observe any
selective quenching of resonances in the 13C–13C dipolar-assisted
rotational resonance (DARR) correlation spectra of either SF or LF,
when the PC was located either in the external hydrophilic head
groups (Fig. 1a, left panels) or the internal hydrophobic tails of the
lipid molecules (Fig. 1a, right panels). This analysis indicates that,
in contrast to OB*, the rigid β-sheet cores of neither SF or LF are
able to interact significantly with the lipid bilayer. Nor do they
appear to interact with the surface of the bilayer, as the core of the
OA* species does.
To further study the interaction of the OB*/SF/LF species with
the lipid bilayer with a different technique, we then analyzed the
abilities of these species (10 µM monomer equivalents), to
interact and bind the same SUVs, using far-UV CD as a
spectroscopic probe. In each case, the spectrum of the aggregates
without SUVs was subtracted from that acquired in their
presence, so that the spectrum of the region of the protein
interacting with SUVs could be obtained (Fig. 1b). While the
acquisition of α-helical structure by M results in large changes in
its CD spectrum upon interaction with lipids25, the observed
spectral changes were progressively smaller for OB*, SF, and LF
(Figure S2f). The changes in the CD spectra of the fibrils cannot
be attributed only to the acquisition of helical structure (as in
OB*), but also to the appearance of random coil structure
(Fig. 1b). Overall, the far-UV CD data indicate that the OB*, SF,
and LF are able to interact with SUVs but with a progressively
decreasing affinity, and that the interaction in each case results in
the acquisition of some helical structure, likely to be in the
unstructured and MAS ssNMR-invisible N-terminal region of the
protein25, which is readily accessible in OB* but significantly less
accessible in the fibrils.
To analyze whether or not the differences in the interaction of
the prefibrillar OB* and the fibrils with lipid vesicles are
reflected in differences in their ability to disrupt membrane
integrity, we compared their rates and extent of induced calcein
release using SUVs composed of POPS lipids containing calcein
molecules trapped in their interior. We found that OB*
induced a rapid and substantial calcein release, with ca. 30%
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of maximum release at the first time point of measurement, and
reaching the maximum level (ca. 90% of maximum release) after
2 min of incubation at a protein:lipid ratio of 1:100. SF/LF
caused, however, a much slower and very significantly reduced
calcein release (ca. 30% release after 5 min) under identical
conditions (Fig. 1c).
Taken together, these findings indicate that fibrils can interact
with the membrane surface likely through the N-terminal region
of the protein, but do not cause significant disruption of the lipid
bilayers as they cannot insert their β-sheet core, whereas
prefibrillar OB* are particularly effective in disrupting membrane
integrity by inserting their partially-formed β-sheet core.
Fig. 1 αS fibrils interact weakly with the surface of the lipid bilayer of synthetic membranes. a PRE effects measured using MAS ssNMR for OB*/SF/LF
using SUVs with DOPE:DOPS:DOPC lipid composition (molar ratio of 5:3:2) with a paramagnetic center (PC) on the bilayer surface on the hydrophilic head
group (left) or in the membrane interior at carbon 16 of the lipid chain (right). 13C–13C DARR spectra measured in the presence and absence of the PC-
labeled lipids are shown in blue and red, respectively. For comparison, the plots of OB* are drawn using OB* data from our previous investigation8.
b Changes in the far-UV CD spectrum of 10 μM OB*/SF/LF and increasing concentrations of SUVs: 1 mM (red), 2 mM (blue), and 8mM (yellow). The
spectra in the absence of SUVs was subtracted in each case from that acquired in their presence. c Calcein release from SUVs (% of total intravescicular
calcein—signal normalized with respect to the treatment with 1% v/v Triton X-100, see Supplementary Information for more details) upon incubation of
the vesicles with the indicated αS species.
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αS fibrils are largely localized at the surface of the cellular
membrane. To improve our understanding of the molecular
mechanisms underlying PD pathogenesis and progression, we
have started our experiments on SH-SY5Y neuroblastoma cells
because of their human origin and because these cells express
tyrosine hydroxylase (TH), dopamine-beta-hydroxylase, and the
dopamine transporter, thus recapitulating many characteristics of
human dopaminergic neurons. We initially investigated the
ability of OB*/SF/LF (0.3 µM monomer equivalents) to interact
with the plasma membrane and penetrate into the cytosol of SH-
SY5Y cells, when incubated in the cell medium (CM) for 1 h. The
αS species (green channel) were counterstained and analyzed by
confocal scanning microscopy at the cellular apical, median, and
basal planes of the plasma membrane (red channel) parallel to the
coverslip (Fig. 2a), to make a clearer distinction between intra-
cellular vs extracellular αS pools8. M and OA* interacted weakly
with the cellular membranes and hardly entered into the cells,
whereas OB* and, to a lesser extent SF, were effectively able to
cross the cellular membrane (Fig. 2a). Higher intracellular protein
levels (median planes) were measured after 1 h of treatment with
OB* with respect to SF and LF (1377 ± 62, 624 ± 106% and 322 ±
54%, respectively) relative to the very low signal of endogenous αS
in untreated cells, taken as 100% (Fig. 2a). Similar results were
obtained from the semi-quantitative analysis of the intracellular
number of αS puncta (Figure S3a). Notably, a mild protease
treatment with 0.05% trypsin at 4 °C, that digested all the protein
molecules exposed on the cell membrane, including the surface-
bound OB*, drastically reduced the green-fluorescent signal at the
Fig. 2 αS fibrils are largely localized at the surface of the cellular membrane but ROS generation correlates with the intracellular αS pool. a
Representative confocal scanning microscope images showing the basal, median, and apical sections of SH-SY5Y cells treated for 1 h with the indicated αS
species at 0.3 μM and the median sections of untreated cells. Red and green fluorescence indicates the cell membranes and the αS species revealed with
wheat germ agglutinin (WGA) and polyclonal anti-αS antibodies (Ab52168, Abcam), respectively. The histogram on the right reports a semi-quantitative
analysis of the intracellular and extracellular αS-derived fluorescence data expressed as the percentage of endogenous αS fluorescence. b Dependence of
ROS production on the intracellular αS-derived fluorescences in SH-SY5Y cells treated with αS species. ROS values reported in Fig. S5 were plotted against
the αS-derived fluorescence values reported in Fig. S4d of cells treated with OB* and SF at the corresponding concentrations. c Representative confocal
scanning microscope images showing mitochondrial superoxide production detected with MitoSOX probe in living SH-SY5Y cells. Red and green
fluorescence indicates MitoSOX staining and αS labeled with AF488 dye, respectively (six independent experiments with one internal replicate).
d Dependence of mitochondrial superoxide production on the intracellular AF488-derived fluorescence signal in SH-SY5Y cells treated with αS species.
Experimental errors are S.E.M. (n= 4 with three internal replicates in panels (a), (b); n= 6 in panel (d) with one internal replicate). Samples were analyzed
by one-way ANOVA followed by Bonferroni’s multiple comparison test relative to untreated cells (in panel a, *P < 0.05, **P < 0.01, ***P < 0.001; in panel
b, P < 0.001; in panel d, P < 0.001). A total of 200–250 cells were analyzed per condition.
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apical planes (Figure S3b), without any significant modification of
intracellular αS aggregates at the median planes of SH-SY5Y cells
(Figure S3b). These results indicate that the signal observed at
median planes arose, indeed, from the internalized OB*. More-
over, inhibition of endocytosis, either by a pharmacological
treatment with dynasore or by a temperature-mediated blockage,
significantly decreased, but did not cancel, the amount of intra-
cellular aggregates in treated cells (Figure S3b), indicating that the
influx of OB* through the membrane bilayer is attributable to a
mixture of passive diffusion and endocytosis.
The ratio between the protein signal at the median planes and
the total protein signal from all planes revealed that ~71%, 13%
and 6% of the OB*, SF, and LF were found to penetrate the cells
after 1 h of incubation, respectively (Fig. 2a). Thus, most of the
αS-derived signal was localized at the plasma membrane in cells
exposed to SF/LF, respectively.
When SH-SY5Y cells were exposed to OB*, SF, and LF for
longer time periods (3, 6, and 24 h) a progressive and significant
increase in intracellular species at cellular median planes was
observed, although in cells treated with SF/LF the intracellular
pool remained smaller than the extracellular one, even after 24 h,
while for OB* ca. 90% of the protein is intracellular at already 3 h
of incubation (Figure S3c).
A dose-dependent analysis revealed that, for both OB* and
SF, similar effects were observed at lower αS concentrations with
a clear dose-dependence, although at higher αS concentrations,
no significant increase in intracellular αS levels was detected
(Figure S4a,b,d), likely as a result of the agglutination of
aggregated αS species at high concentrations27. Moreover, OB*
showed a similar bell-shaped protein concentration dependence
for both the intracellular and the total αS-derived fluorescence
with the amount of the oligomers inside the cells found to be
directly proportional to the mass concentration of oligomers
interacting with the plasma membrane (Figure S4d,e). By
contrast, the total amount of SF bound to the membrane
was much higher than the intracellular fraction at any αS
concentration (Figure S4b,d,e). Furthermore, concentrations
higher than 0.3 µM resulted in an increase in the number of
fibrils bound to the cell membrane but not in the quantity of
intracellular protein (Figure S4b,d,e). These results indicate that
the extent to which OB*, though not SF, has been taken up by
the cells correlates with the amount of αS interacting with the
plasma membrane.
ROS generation correlates with the intracellular αS pool. The
generation of intracellular reactive oxygen species (ROS) is one of
the inflammatory sequelae associated with protein aggregate
treatment28 and one of the earliest biochemical changes experi-
enced by cells exposed to pathogenic αS aggregates6. We have also
previously found that OB*, and to a lesser extent SF, induce a
significant increase in ROS levels in SH-SY5Y cells, whereas OA*
and M were found to cause a non-significant effect8. Here we
extended the measurements to various αS concentrations of OB*/
SF/LF, with the aim to relate a readout of toxicity with that of αS
penetration and cell surface binding. ROS production showed
again a bell-shaped αS concentration dependence when the dif-
ferent αS species were added for 15 min to the CM of SH-SY5Y
cells, with a maximum effect at 0.3 µM (Figure S5a,b). A plot of
the degree of the ROS increase, measured at the different con-
centrations of OB*/SF, against the intracellular αS levels, using
the fluorescent signals obtained for OB*/SF, revealed a very sig-
nificant positive correlation (R = 0.90, p < 0.001) (Fig. 2b). By
contrast, no significant correlation was found between ROS
increase and total αS, i.e., sum of intracellular and extracellular
pools (R= 0.046, p > 0.05; Figure S5c).
We also monitored concomitantly the generation of mitochon-
drial superoxide ions and intracellular αS levels in living SH-
SY5Y cells exposed for 1 h to 0.03, 0.1, and 0.3 µM of OB*/SF
labeled with AF488 dye or to 250 µM H2O2 as a positive control
(Fig. 2c and S5d). The increase in intracellular αS levels (green
channel) correlated positively with the mitochondrial superoxide
production (red channel) in a dose-dependent relationship (R=
0.91, p < 0.001) (Figs. 2c, d and S5d). These results indicate that
the generation of ROS and mitochondrial superoxide is related to
the level of intracellular αS.
αS fibrils gradually destabilize membrane integrity resulting in
neuronal dysfunction. In order to confirm the ability of the
different αS species to destabilize the membrane permeability of
cells, we assessed the release of the fluorescent probe calcein-AM,
previously loaded into the cells29. Calcein acetoxymethyl
(Calcein-AM) is a substrate that passively crosses the cell mem-
brane and in the cytosol is hydrolyzed by the enzyme esterase to a
polar green-fluorescent product (calcein) that is retained into cells
with intact membrane. The addition to the CM for 1 h of 0.3 μM
OB* and, to a lesser extent, SF, generated a significant leakage of
calcein, such as 73 ± 2% and 41 ± 3% in rat primary cortical
neurons and 64 ± 4% and 37 ± 2% in human SH-SY5Y cells,
respectively (Fig. 3a). Calcein leakage suggests a permanent dis-
ruption of neuronal bilayers following the aggregates penetration
through membranes and their intracellular localization. By con-
trast, all other αS species, including LF, caused negligible calcein
release at this incubation time (Fig. 3a).
Accordingly, a similar pattern of cytosolic Ca2+ dyshomeostasis
was observed for the different αS species in cortical neurons
and SH-SY5Y cells (Fig. 3b), as previously reported13,30,31. In
particular, following 15min treatment at an αS concentration of
0.3 µM, OB* and, to a lesser extent, SF and even lesser for LF,
triggered a significant influx of Ca2+ into cortical neurons and SH-
SY5Y cells (551 ± 31%, 356 ± 50%, 261 ± 16 and 380 ± 16, 230 ± 27
and 124 ± 11 for the three species and two cell types, respectively),
whereas all other αS species caused a negligible Ca2+ influx
(Fig. 3b). No fluorescent signal was apparent when SH-SY5Y cells
were cultured in a Ca2+-free CM (Figure S6a,b). Lower effects were
observed at lower and higher protein concentrations with a clear
bell-shaped dose response (Figure S6a,b).
Real-time intracellular calcium measurements in SH-SY5Y
living cells showed a steady basal fluorescence in the absence of
extracellular aggregates and a rapid increase in the intracellular
Ca2+ levels following the addition of OB* and, with slower
kinetics, of SF up to 30 min (Figure S6c). Notably, we also
observed a faster increase of intracellular Ca2+ for OB* than SF
and LF treatment at longer time periods in SH-SY5Y cells
(Fig. 3c).
We further monitored whether the ability of αS aggregates to
cause ionic dyshomeostasis resulted in the activation of caspase-3,
a well-recognized apoptotic marker32. To this aim, we used a
relevant PD model such as human iPSC-derived dopaminergic
neurons expressing TH, a typical dopaminergic neuron marker
(~75% of total cells), as well as the microtubule-associated protein
2 (MAP-2), a typical mature neuron marker, after 14–18 days of
culture (Fig. 3d). A significant caspase-3 activation (444 ± 13%)
was found in iPSC-derived dopaminergic neurons following
treatment for 24 h with 0.3 µM OB* with respect to untreated
cells (Fig. 3e, f). Both SF and LF caused a caspase-3 activation of
337 ± 31% and 265 ± 9%, respectively, in the same neurons after
24 h of treatment (Fig. 3e, f). Accordingly, similar results were
observed in SH-SY5Y cells treated with OB*/SF/LF, whereas no
apoptosis was apparent in cells treated with 0.3 µM OA* or M
(Fig. 3f).
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A consistent trend was observed for the mitochondrial
dysfunction, as revealed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction inhibition assay33
carried out on both primary rat cortical neurons and SH-SY5Y
cells (Fig. 3g). Since αS is physiologically N-terminally acetylated
in vivo34, representative experiments were repeated with OB*
formed from the N-acetylated αS. It has been recently reported
that no significant differences were observed in the structural
properties of αS species following N-terminal acetylation8.
Consistent results were obtained in the present study, using
calcein release and MTT reduction as cell viability readouts
(Figure S7a,b). Similar results were also obtained with the ultra-
Fig. 3 αS fibrils gradually destabilize membrane integrity resulting in neuronal dysfunction. a Representative confocal microscope images showing
primary rat cortical neurons loaded with the calcein-AM probe for 10min and then treated for 1 h with the indicated 0.3 µM αS species. Semi-quantitative
analyses of the calcein-derived fluorescence signal in primary rat cortical neurons and SH-SY5Y cells. b Representative confocal microscope images
showing the Ca2+-derived fluorescence in primary rat cortical neurons treated for 15 min with the indicated 0.3 µM αS species and then loaded with the
Fluo-4 AM probe. Semi-quantitative analysis of the intracellular Ca2+-derived fluorescence in primary rat cortical neurons and SH-SY5Y cells. c Time-
course analysis of the intracellular Ca2+-derived fluorescence in SH-SY5Y cells treated for the lengths of time indicated with OB*/SF/LF at 0.3 µM.
d Representative confocal microscope images of human iPSC-derived dopaminergic neurons expressing MAP-2 (ab32454, Abcam) and TH (sc-25269,
Santa Cruz Biotechnology) markers at 14–18 days of maturation (three independent experiments with one internal replicate). Approximately 75% of the
cells are TH positive (estimated by immunostaining). Nuclei were stained with DAPI. e Representative confocal microscope images showing caspase-3-
derived fluorescence in human iPSC-derived dopaminergic neurons treated for 24 h with the indicated αS species at 0.3 µM. f Semi-quantitative analysis of
the caspase-3-derived fluorescence in human iPSC-derived dopaminergic neurons and SH-SY5Y cells treated for 24 h with the indicated αS species at
0.3 µM. f MTT reduction in primary rat cortical neurons and SH-SY5Y cells treated for 24 h with the indicated 0.3 µM αS species. In all panels data are
expressed as the percentage of the value for untreated cells. Experimental errors are S.E.M. (n= 3 with two internal replicates and n= 4 with three internal
replicates for cortical neurons and SH-SY5Y cells, respectively, in panels (a), (b); n= 4 in panel c with one internal replicate; n= 3 with two internal
replicates and n= 4 with three internal replicates for iPSC-derived dopaminergic neurons and SH-SY5Y cells, respectively, in panel f; n= 6 with three
internal replicates in panel (g)). Samples were analyzed by one-way ANOVA followed by Bonferroni’s multiple comparison test relative to untreated cells
(in panels a, b, f, and g, *P < 0.05, **P < 0.01, ***P < 0.001). A total of 200–250 cells (a–f) and 150,000–200,000 cells (g) were analyzed per condition.
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clean samples, where the recombinant protein was pretreated to
remove potential lipopolysaccharides, probing ROS detection and
MTT reduction (Figure S7c,d).
Taken together our results indicate that αS SF have lower
ability than OB* to cause fast membrane permeabilization, rapid
intracellular Ca2+ influx and ROS generation in primary neurons
and SH-SY5Y cells, with LF being almost inert; however, SF have
effects closer to OB* and even LF show some effect when
downstream cellular dysfunction, such as metabolic capacity and
apoptotic response, was probed at longer time frames.
αS fibrils gradually release oligomers in vitro. We took
advantage of the conformation-sensitive A11 antibody to inves-
tigate whether the release of toxic oligomers from αS fibrils is
responsible for the observed toxicity of SF. The polyclonal A11
antibody, originally raised against prefibrillar Aβ oligomers, has
been shown to recognize toxic oligomers from various proteins,
but not monomers or fibrils35. The A11 antibody showed a high
affinity for OB*, whereas the absence of any A11-positive cross-
reaction of SF/LF rules out the possibility that a significant
fraction of OB* species was present in the fresh fibrillar samples
at micromolar concentrations (Fig. 4a). Nor did it react with
control nontoxic OA*.
We monitored the ability of αS fibrils to release small oligomers
over time in the absence of cells. Confocal images of SF samples,
incubated in the CM without cells in wells containing a glass
coverslip for 0, 1, 3, and 24 h at 37 °C, resolved by the
conformation-insensitive mouse monoclonal 211 antibody
showed similar populations of αS-derived fluorescence dots
(Fig. 4b). By contrast, αS-derived fluorescence dots increased in
number with incubation time at 37 °C in SF using the
conformation-sensitive A11 antibody, suggesting a slow and
progressive increase in A11 immunoreactivity (Fig. 4b). A slower
time-dependent increase in A11-positive signal was also obtained
with LF following incubation up to 24 h (Figure S8a). Very similar
small dots were apparent in confocal images of OB* sample using
both conformation-insensitive 211 and conformation-sensitive
A11 antibodies following incubation for 0 and 24 h at 37 °C
(Fig. 4b and Figure S8a). No fluorescent signal was evident with
primary and secondary antibodies in the absence of αS aggregates,
ruling out the ability of the antibodies to react with the slides in
the absence of αS species (Figure S8a).
To confirm that the A11 reactivity in aged SF/LF originates
from the release of small oligomers rather than from a
conformational change in SF exposing the A11 epitope, we also
analyzed SF upon incubation for 24 h at 37 °C using dynamic
light scattering (DLS) (Figure S8b). The SF sample at 0 h showed
a large peak at ~600 nm, but a small peak at ~20 nm became
increasingly apparent with time (Figure S8b). The size distribu-
tion in the small peak was consistent with that detected in OB*
sample incubated up to 24 h at 37 °C (Figure S8b). This indicates
that αS fibrils can release A11-positive oligomeric species
following incubation at 37 °C in vitro.
αS fibrils gradually release oligomers that are ultimately
responsible for their toxicity. Then, we investigated whether αS
SF can release small oligomers following their interaction with
cellular membranes. We probed the nature of the protein species
able to penetrate into human iPSC-derived dopaminergic neu-
rons using the A11 antibody in immunofluorescence experiments
(Fig. 4c). Confocal images showed a remarkable A11-positive
signal in neurons treated for 24 h with OB*, SF, and LF (Fig. 4c)
with respect to untreated cells (Figure S8c), indicating the pre-
sence of αS oligomeric species similar to OB* inside the cells
upon treatment with SF/LF. When SH-SY5Y cells were exposed
to OB* for 3 h, a dramatic increase (474 ± 26%) in A11-positive
intracellular species at median planes was observed with respect
to untreated cells (Fig. 4d, e and Figure S8c). In particular, ~62%
of the OB* sample was found to penetrate the cells (defined as the
ratio between the intracellular fluorescence at the median planes
and the total fluorescence at all planes), in good agreement with
the fraction of intracellular protein obtained by αS conformation-
insensitive antibody (Ab52168) (Fig. 2a). Cells exposed to SF for
3 h and to LF for 6 h also exhibited a significant increase (258 ±
6% and 199 ± 13%, respectively) in the intracellular A11-positive
signal (Fig. 4d, e), indicating a progressive penetration of αS
oligomeric species similar to OB*. Indeed, the majority of the
A11-derived fluorescence signal was located in the interior of the
cells (87 ± 7% and 97 ± 6% for SF and LF, respectively), suggest-
ing that the A11-positive oligomers had been able to cross the
membrane.
To investigate whether the intracellular A11-positive signal
could arise from the conversion of endogenous αS into A11-
positive species, we first quantified the intracellular and total
fluorescences at different OB* doses (Figure S9a-c). A bell-shaped
protein concentration dependence was found for both, with the
amount of the A11-positive species inside the cells found to be
directly proportional to the mass concentration of those species
interacting with the plasma membrane (Figure S9a-c), confirming
the results obtained with a conformation-insensitive antibody
(Figure S4a-e). Second, we quantified the intracellular and total
A11-derived fluorescence following 15 min and 24 h of OB*
treatment (Figure S9d). Neither the intracellular nor the total
A11-derived fluorescence at 24 h exceeded the total A11-derived
fluorescence observed early at 15 min, suggesting that the
endogenous αS was not recruited into A11-positive species.
When we monitored the intracellular A11-positive signal as a
function of time, we found exponential kinetics for OB*, but
sigmoidal kinetics for both SF and LF (Fig. 4e). The results
obtained with the A11 antibody were also confirmed with another
conformational-sensitive antibody such as Syn33, that has been
previously shown to specifically recognize αS oligomers36. Here,
the Syn33 antibody showed a high affinity for OB* and a very low
cross-reaction with SF/LF in the dot-blot assay (Figure S8d).
When SH-SY5Y cells were exposed to OB* for 3 h, a dramatic
increase (407 ± 24%) in Syn33-positive intracellular species at
median planes was observed with respect to untreated cells
(Figure S8e,f), in good agreement with the immunostaining data
obtained by A11 antibody (Fig. 4c-e). Cells exposed to SF for 3 h
and to LF for 6 h also exhibited a significant increase (177 ± 22%
and 173 ± 13%, respectively) in the intracellular Syn33-positive
signal (Figure S8e,f). These results are in agreement with the idea
that a lag time is required for oligomer release from SF/LF before
cell penetration.
To have equivalent molar concentrations of fibril particles
(numbers/volume) rather than monomer equivalents, we have
estimated the same fibril number concentrations for SF/LF
(corresponding to a higher mass concentration for LF, see
“Methods”). We have thus chosen two different mass concentra-
tions where the fibril particle concentrations are similar (0.03 µM
SF and 0.3 µM LF, both monomer equivalents), finding similar
toxic effects using ROS and Ca2+ probes (Figure S8g).
As αS toxicity depends on the time of cellular exposure to the
deleterious αS species, we monitored MTT reduction following
incubation of SH-SY5Y cells for different lengths of time with
0.3 μM OB*/SF/LF. We observed a similar order of rates for the
three species, with the OB* being the most rapid and the LF being
the slowest in causing a decrease of MTT reduction (Fig. 4f).
Moreover, a plot of the degree of MTT reduction against the
intracellular A11-positive αS levels, using the data obtained at all
time points and for OB*/SF/LF, revealed a very significant
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Fig. 4 αS fibrils gradually release oligomers that are ultimately responsible for their toxicity. a Dot-blot analysis of αS species probed with
conformational specific antibody A11 (AHB0052, Thermo Fisher Scientific), OC (AB2286, Sigma-Aldrich), conformation-insensitive polyclonal anti-αS
antibody (ab52168, Abcam) and conformation-insensitive monoclonal 211 antibody specific for human αS (sc12767, Santa Cruz Biotechnology).
b Representative confocal microscope images showing SF (at 0.3 μM) incubated in CM without cells in wells containing a glass coverslip for 0–24 h at
37 °C. Representative images of OB* incubated for 24 h were also shown as positive control. The green-fluorescent signals derive from the staining with
mouse monoclonal 211 anti-αS antibodies and rabbit anti-oligomer A11 polyclonal antibodies, in the first and second rows, respectively, and then Alexa-
Fluor 514-conjugated anti-mouse or anti-rabbit secondary antibodies (three independent experiments with one internal replicate). c Representative
confocal scanning microscope images showing human iPSC-derived dopaminergic neurons treated for 24 h with OB*/SF/LF at 0.3 µM. Red and green
fluorescence indicates mouse anti-MAP-2 antibodies (ab11267, Abcam) and the A11-positive prefibrillar oligomers, respectively. d Representative confocal
scanning microscope images showing the median sections of SH-SY5Y cells treated for the lengths of time indicated with OB*/SF/LF at 0.3 µM. Red and
green fluorescence indicates the cell membranes labeled with WGA and the A11-positive prefibrillar oligomers, respectively (three independent
experiments with four internal replicates). e Kinetic plots reporting A11-intracellular fluorescence following the addition of 0.3 μM of the indicated αS
species to SH-SY5Y cells. The continuous lines through the data represent the best fits to exponential and sigmoidal functions (see “Methods”), for OB*,
SF, and LF, respectively. f Kinetic plots reporting the MTT reduction versus time elapsed following addition of 0.3 μM of the indicated αS species to SH-
SY5Y cells. g Dependence of MTT reduction on the penetration of A11-positive αS in SH-SY5Y cells treated with αS species. MTT reduction values reported
in (f) plotted against the αS-derived intracellular fluorescence values reported in (e) of cells treated with OB*/SF/LF at the corresponding times.
Experimental errors are S.E.M. (n= 3 with four internal replicates in panel (e); n= 4 with three internal replicates in panel (f); n= 3 with four internal
replicates and n= 4 with three internal replicates for MTT reduction and intracellular A11-positive aS, respectively, in panel (g). Samples were analyzed by
one-way ANOVA followed by Bonferroni’s multiple comparison test relative to untreated cells (in panels e and f, *P < 0.05, **P < 0.01, ***P < 0.001; in
panel g, P < 0.001). A total of 200–250 cells (e) and 150,000–200,000 cells (f) were analyzed per condition.
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negative correlation (R= 0.91, p < 0.001, Fig. 4g), indicating that
the amount and kinetics of released oligomers match the observed
levels and kinetics of toxicity in cellular systems.
Visualization of αS fibrils outside and oligomers inside cells at
high resolution. To evaluate further the nature of the αS species
that were found inside the cells, we used the super-resolution
STED microscopy37 on rat primary cortical neurons and the
mouse monoclonal 211 anti-αS antibody (Fig. 5a–d). This
conformation-insensitive antibody was raised against residues
121–125 of human αS (sequence DNEAY), so is unable to interact
with endogenous rat αS (sequence SSEAY). Accordingly, rat
cortical neurons treated with the antibody in the absence of
exogenous human αS did not reveal any green fluorescence
arising from endogenous αS (Fig. 5a). By contrast, neurons
exposed to human αS-derived OB* for 14 and 24 h exhibited
green-fluorescent punctae, which appeared to be small and
globular at the very high magnifications allowed by STED
microscopy (Fig. 5b, arrows in the left image magnification).
Neurons treated with SF for 14 and 24 h, however, showed αS
aggregates outside the cells or attached to the membrane that, at
high magnification, appeared fibrillar in morphology with a
length distribution of the same order of magnitude as that
Fig. 5 Visualization of αS fibrils outside and oligomers inside cells at high resolution. a, b Representative STED images of primary rat cortical neurons
that were untreated (a) or treated (b) with OB* (left) and SF (right) for 14 and 24 h. Red and green fluorescence indicates the cell membranes and the αS
species revealed by WGA and the conformation-insensitive and human αS-specific 211 antibodies (sc12767, Santa Cruz Biotechnology), respectively.
Higher magnifications of the αS species are shown in the boxed areas (three independent experiments with two internal replicates). c Semi-quantitative
analysis of the intracellular and extracellular 211-derived fluorescence data referring to panel (b). Experimental errors are S.E.M. (n= 3 with two internal
replicates). Samples were analyzed by one-way ANOVA followed by Bonferroni’s multiple comparison test relative to cells treated with OB* for 14 and 24 h
(in panel c, §§P < 0.01, §§§P < 0.001). d 3D reconstruction of the z-stack analysis (5-μm-thick slices) of the specimens shown in panel (b). A primary
neuron was virtually dissected on the zy plane to show more clearly the extracellular (top) and intracellular (middle) αS species. A total of 40–60 cells
were analyzed per condition (three independent experiments with four internal replicates). e Representative STED images of SH-SY5Y cells that were
treated with AF488-OB* (left) and AF488-SF (right) for 24 h. Red and green fluorescence indicates the cell membranes labeled with WGA and αS labeled
with AF488 dye, respectively. Higher magnifications of the αS species are shown in the boxed areas (three independent experiments with one internal
replicate). f 3D reconstruction of the z-stack analysis (5-μm-thick slices) of the specimens shown in panel (e). Other details as in panel d (three
independent experiments with one internal replicate). In all panels blue arrows indicate either fibrillar or oligomeric αS species.
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determined by AFM (Fig. 5b, arrow in the top right image
magnification). The same images also showed a number of small
and globular intracellular αS species, with a morphology that
resembled the intracellular OB* (Fig. 5b, arrow in the bottom
right image magnification). These can only include exogenous
human αS given the specificity of the 211 antibody. The 211-
derived green-fluorescent signals of cortical neurons treated with
OB* and SF for 14 and 24 h were consistent with the results
obtained with Ab52168 and A11 antibodies (Fig. 5c), although
the reliability of STED quantification is limited by the selective
photobleaching of fluorophores coupled with super-resolution
microscopy.
When z-stack analysis was used to perform the 3D reconstruc-
tion of the primary neurons treated with OB*, small oligomeric
species attached on the outer leaflet of the plasma membrane
(small green punctae on the top) and penetrated into the cytosol
(small green punctae in the middle) were evident (arrows
in Fig. 5d). By contrast, neurons treated with SF showed fibrillar
species attached to the extracellular side of the cell membrane
along with intracellular globular species similar to OB* (arrows in
Fig. 5d). STED imaging was repeated on human SH-SY5Y cells
treated with OB* and SF labeled with the fluorescent AF488 dye,
clearly showing small oligomers with globular morphology on the
membrane surface and inside the cells and only inside the cells,
respectively (Fig. 5e, f). We performed this experiment with a low
ratio of AF488 labeled OB* and SF (generated by mixing 90 and
10% of unlabeled and labeled αS monomers), thus ensuring the
absence of significant modifications to the properties of OB* and
SF as previously reported6,8.
These findings reveal that the αS species detected in neurons
and SH-SY5Y cells by confocal microscopy and STED using
different probes arise from exogenous human αS derived from
SF/LF, rather than endogenous rat αS converted in oligomeric
form by a seeding process. Moreover, to assess whether the
toxicity induced by fibrils could originate from a released M that
could progressively convert into oligomers by a process of
secondary nucleation27, we exposed the SH-SY5Y cells to SF
(0.03 µM) for 15 or 180 min in the absence or presence of a 10-
fold excess of M (0.3 µM). We have chosen a time of 180 min, as
the toxicity observed with cells exposed to SF/LF was already
evident within 180 min (Fig. 3c). The results did not show any
significant difference in the degree of Ca2+ influx between the
different conditions (Figure S10), indicating that the oligomers
observed are directly generated by the disaggregation or
fragmentation of fibrils under the conditions of study.
Inhibition of oligomer release from fibrils prevents their
toxicity. To provide further evidence that the fibrils release toxic
oligomers and that these are the major species responsible for the
αS toxicity, we performed an additional set of competitive
experiments. SH-SY5Y cells were exposed to OB*/SF/LF (0.3 µM)
and a 2.5-fold excess of the A11 antibody was added to the CM
for 24 h. Without antibodies, cells treated for 24 h with OB* and,
to a lesser extent SF/LF, showed intracellular small green dots, as
revealed by the Ab52168 antibody (Fig. 6a, b). Addition of A11
antibody to the CM containing αS species significantly reduced
the OB* penetration by ~68% (Fig. 6a, b) and abolished com-
pletely the OB* cytotoxicity (Fig. 6c). The reduction of small
green dots in the cytosol of A11-treated cells exposed to SF and
LF (by ~80% and ~77%, respectively) also resulted in a complete
recovery of cell viability (Fig. 6a–c). This data suggest that A11
antibody binds oligomeric species that are released from SF/LF,
thus preventing their cellular uptake and their downstream
effects. We repeated the experiments using the conformation-
sensitive OC antibody, raised against fibrillar species38, found
here to react with SF/LF, but not OB* (Fig. 4a). The addition of
OC antibody to the CM containing SF/LF reduced significantly
the intracellular αS-specific antibody signal (by ~75% and ~63%,
respectively) and their cytotoxicity, without affecting the intra-
cellular fluorescence (reduced only by ~7%) and the toxicity
(reduced only by ~3%) when added to the CM containing OB*
(Fig. 6a–c).
Moreover, a plot of the degree of MTT reduction against the
intracellular αS levels using the data obtained for OB*/SF/LF with
or without A11/OC antibodies, revealed a very significant
negative correlation (R= 0.88, p < 0.001) (Fig. 6d), confirming
that the most inherently toxic αS species are β-sheet containing
oligomers, which can either be formed during the self-assembly of
the protein into amyloid fibrils or released from fibrillar species
once they are formed.
Discussion
In this work, NMR and CD data show that the β-sheet core of the
αS fibrils is unable to establish persistent interactions with either
the surface or the internal regions of the lipid bilayers, with the
interactions restricted to the binding of the disordered N-terminal
region of αS onto the surfaces of the lipid bilayers. Accordingly,
following their addition to the CM, the SF and LF forms of αS
appear to be largely localized at the surface of the plasma
membrane on the timescale of the experiments studied here, at
which toxicity is observed. The total quantity of SF/LF bound to
the cell membrane was not found to correlate with the degree of
cell dysfunction or αS penetration. Therefore, the association
between SF or LF and cellular membranes is not sufficient to
account for the toxicity of these species. On the contrary, most of
the prefibrillar OB* species that interact with the neuronal
membrane appear to penetrate into the cytosol, and the amount
of intracellular OB* was found to be directly proportional to the
mass concentration of the species that interact with the plasma
membrane and the resulting toxicity.
The biological analyses revealed that prefibrillar OB* species
induce a rapid dysregulation of calcium and redox status home-
ostasis, in agreement with our previous results6,8,12,13,39.
Although the fate of αS aggregates once they enter the cells needs
further investigation, the influx of OB* through the membrane
bilayer is partially mediated by endocytosis. The uptake of OB*
was found to result in further membrane disruption (as indicated
by calcein release), mitochondrial dysfunction, and apoptosis.
Importantly, the same cascade of events was observed for the
fibrillar samples, although with remarkably different kinetics. Our
results, therefore, indicate that αS aggregates with a β-sheet core
and solvent-exposed hydrophobic surfaces appear to be able to
induce cellular damage, although the time scales and levels of
observed toxicity depend on the nature (oligomeric vs fibrillar)
and size of the aggregates.
Thus, the question remains as to how fibrillar species exert
their toxicity. According to our results, the toxic effects of the
fibrils appear to correlate directly with the quantity of αS that
penetrate into the cells after interacting with the cellular mem-
branes and cause calcium uptake, ROS formation, membrane
permeabilization to calcein, caspase-3 activation, and mitochon-
drial dysfunction. The dissociation of αS fibrils into soluble αS
species, likely to include a low proportion of monomers in
addition to oligomers, have also been observed in recent studies
to occur under conditions close to physiological6,40. Using con-
focal microscopy and the A11 and Syn33 antibodies, which are
specific for ‘soluble prefibrillar oligomers’35,36, we found that the
species that can penetrate into the cells were A11- and Syn33-
positive in all cases, not only when the cells were treated
with OB*, but also with SF and LF species that are A11- and
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Syn33-negative per se. In a cell-free context, SF/LF were found to
slowly release A11-positive species and DLS indicated a slow
release of small-sized species. The appearance of A11-positive
aggregates from the fibrillar species was relatively slow, with rates
and overall kinetic traces that closely match the time course of
toxicity for SF/LF. This also explains why fibrils caused a minor
and slower calcein release from SUVs. Finally, using STED super-
resolution microscopy in rat primary cortical neurons coupled
with 3D analysis and the monoclonal 211 antibody that recog-
nizes only the exogenous human αS, we provide further evidence
for the oligomeric, rather than fibrillar, morphology of the αS
species released from exogenous αS fibrils upon interaction with
the cell membrane and later entering the cytosol. When z-stack
analysis was used to perform the 3D reconstruction, the release of
oligomeric species from SF was also evident inside the cells
exposed to the fluorescently labeled AF488-SF in the absence of
any antibody.
Our finding that LF are less toxic than SF can be attributed to
their lower proportion of fibrillar ends at the same mass con-
centration. As oligomer release occurs from fibril ends, this fea-
ture will result in a slower release of oligomers. Moreover, LF
showed a lower diffusion capacity in the CM, and a reduced
ability to interact with the cells, than SF. These conclusions are in
line with previous reports obtained with the amyloid-beta (Aβ)
peptide associated with Alzheimer’s disease that have revealed the
lipid-mediated depolymerization of nontoxic fibrils of Aβ into
toxic A11-positive oligomers, which were also shown to resemble
the oligomers formed de novo during fibril assembly41. They are
also in agreement with the general proposition that any fibrillar
species that accumulate in tissue can represent a source of soluble
toxic oligomers6,42, and with the halos of soluble oligomers
observed to surround amyloid plaques of Aβ in mouse brains43.
In a recent study, we have found that SF species analyzed in the
present paper are able to induce PD-like pathology by a spreading
process when injected into the brains of healthy mice, whereas the
OB* species were only able to induce local toxicity in the region
of brain injection, without signs of seeding and spreading, as it
was expected, given their kinetically trapped nature24. It is pos-
sible, however, that the OB-like species that we have observed to
be released from fibrils in the present study, in addition to con-
tributing to the induction of toxicity, could also enhance the
generation of new aggregates, as they might have elongation
Fig. 6 Inhibition of oligomer release from fibrils prevents their toxicity. a Representative confocal scanning microscope images showing the median
sections of SH-SY5Y cells treated for 24 h with the indicated αS species at 0.3 μM, in the absence or presence of A11 (AHB0052, Thermo Fisher Scientific)
and OC (AB2286, Sigma-Aldrich) antibodies at 1:2.5 molar ratio. Red and green fluorescence indicates the cell membranes and the αS species revealed
with WGA and polyclonal anti-αS antibodies (ab52168, Abcam), respectively. The arrows in the images show the intracellular green-fluorescent punctae.
b Semi-quantitative analysis of the green fluorescence signal referring to panel (a) and derived from intracellular αS species expressed as the percentage of
untreated cells. c MTT reduction in SH-SY5Y cells treated for 24 h with the indicated αS species at 0.3 µM in the absence or presence of A11 and OC
antibodies (1:2.5 molar ratio). d Dependence of MTT reduction (values reported in panel c) on the αS-derived fluorescence values in cells treated with
OB*/SF/LF (values from panel b) in the absence or presence of A11 and OC antibodies (1:2.5 molar ratio). In all panels, experimental errors are S.E.M. (n=
4 with three internal replicates). Samples were analyzed by one-way ANOVA followed by Bonferroni’s multiple comparison test relative to untreated cells
(in panels b and c, *P < 0.05, **P < 0.01, ***P < 0.001) and cells treated with the αS species (in panels b and c, §P < 0.05, §§P < 0.01, §§§P < 0.001). In panel
d, P < 0.001. A total of 200–250 cells (a, b), and 150,000–200,000 cells (c) were analyzed per condition.
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capabilities similar to those of their fibrillar precursors, unlike
OB* species4.
In conclusion, our results suggest that αS fibrils, particularly
the small ones, have a doubly deleterious effect. The first has been
explored previously and results from a transfer from neuron-to-
neuron contributing to the slow but progressive diffusion of Lewy
body pathology in different brain areas. Indeed, some αS fibril
polymorphs have been observed to be internalized by cells22,23
and possibly contribute to pathology spreading17–21,24. The sec-
ond effect stems from the release of prefibrillar oligomeric species
causing an immediate dysfunction of the neurons in the vicinity
of these species. Such oligomeric species could also contribute to
pathogenesis via neuron-to-neuron spreading by their direct cell-
to-cell transfer or by generating new fibrils, following their neu-
ronal uptake.
Thus, molecules able to prevent the formation of toxic oligo-
mers of αS during the aggregation process, such as
aminosterols44–46, or to interact directly with such species, for
example the A11 antibody, or to prevent their release from the
fibrillar species, such as the OC antibody, are able to suppress αS
toxic behavior. Indeed, these three mechanisms have been shown
to be used by different molecular chaperones to protect cells from
amyloid aggregation, some inhibiting oligomer formation, other
binding to and neutralizing the effects of preformed oligomers,
and other binding preferentially to fibril ends47–51. These features
are of considerable interest in the design of therapeutic approa-
ches targeting α-synucleinopathies and other systems in which
protein aggregation is linked to neurodegeneration.
Methods
Purification of αS monomers and formation of αS OA* and OB*, SF and LF.
The recombinant human αS was over-expressed in E. coli BL21 cells (Agilent, UK)
and purified as a monomeric fraction4. OA* were generated by incubating ca. 200
μM of αS in PBS pH 7.4 with ten molar equivalents of (-)-epigallocatechin-3-gallate
(EGCG) (Merck, Darmstadt, Germany) for 48 h at 37 °C. After the incubation,
excess of compound and monomeric protein was removed by six consecutive cycles
of filtration through 100 kDa centrifuge filters (Merck). For the isolation of OB*,
purified αS was dialyzed against miliQ water and lyophilized for 48 h in aliquots of
6 mg. The aliquots were resuspended in 500 μL of PBS pH 7.4 to a final con-
centration of 800 μM, filtered through a 0.22 μm filters and incubated at 37 °C
without agitation for 20–24 h. Resulting fibrils formed during the incubation were
removed by ultracentrifugation at 288,000 × g. Monomeric protein and small oli-
gomers were removed by four consecutive cycles of filtration through 100 kDa
centrifuge filters (Merck)4,8. Final oligomer concentration was determined mea-
suring the absorbance at 280 nm and using the extinction coefficient 5960M−1
cm−1 for the OB*, or by BCA analysis for OA* oligomers (in this later case, the
yield of production was consistently ca. 100%). Both oligomeric samples were kept
at room temperature and were used within 3 days after their production4,8. Long
fibrillar samples (f0) were prepared by incubating monomeric αS at 70 μM (1mg/
ml) in PBS buffer pH 7.4 (0.1M ionic strength) containing 0.01% NaN3 at 37 °C,
under constant agitation (New Brunswick Scientific Innova 43, 200 rpm) for
4–6 days. After this time, each sample was centrifuged (15min at 16,100 × g) and
the fibrillar pellet washed twice with PBS before being resuspended into the
appropriate volume of PBS. As clumping of fibrils was observed52 a second gen-
eration of long fibrils (f1) was prepared by incubating 100 μM monomeric αS with
10 μM of f0 sonicated for 1 min (Bandelin, Sonopuls HD 2070, cycles of 0.3 s of
active sonication followed by 0.7 s of passive interval, 10% maximum power) in 500
μL PBS at 37 °C under quiescent conditions for 13–15 h and then centrifuged as
described above for f0. Samples of short f1 fibrils were generated by sonicating long
f1 fibrils for 20 s using the same apparatus and settings. The concentration of fibrils
was estimated by measuring the absorbance at 275 nm using ε275= 5600M−1 cm−1
after disaggregating an aliquot by the addition of guanidinium chloride to a final
concentration of 4M.
N-terminally acetylated αS was obtained by coexpression of a plasmid carrying
the components of the NatB complex (Addgene) with the pT7-7 plasmid encoding
for human WT αS. The purification protocol of N-terminally acetylated protein
was identical to the non-modified variant and the yield of acetylation was assessed
by mass spectrometry and resulted to be essentially complete.
In a set of experiments, LPS (lipopolysaccharide) ultra-clean, also referred to as
LPS-free, OB* samples were used to study the possible effect of LPS residual
concentrations present in the OB* samples generated from the recombinant
protein. For this, a set of commercial kits to remove the LPS endotoxin and
quantify its content in the different protein samples (Thermo Fisher Scientific,
Waltham, MA, USA) was used.
Fluorescently labeled αS molecules carrying the AF488 dye (Invitrogen,
Carlsbad, CA, USA) were obtained by using the N122C mutational variant6. The
labeled protein was then purified from the excess of free dye by a P10 desalting
column with a Sephadex G25 matrix (GE Healthcare, Chicago, IL, USA) and
concentrated using Amicon Ultra Centricons (Merck, Darmstadt, Germany).
Fluorescent OB* and SF were generated by mixing 90 and 10% of unlabeled and
labeled αS, respectively. The fluorophore at a position near to 122 was reported to
be efficient in following amyloid aggregation and oligomer and fibril stability
without affecting much these properties6. But in any case, the low ratio of labeled to
unlabeled monomers and the C-terminal position of Cys1228, ensured the absence
of significant modifications to the properties of OB* and SF.
ssNMR. PRE data were acquired by performing DARR experiments in ssNMR to
probe the membrane interactions of the rigid region of the oligomers and fibrils8.
All lipids were acquired from Avanti Polar Lipids Inc., Alabaster, AL, USA.
SUVs of the relevant lipid compositions were prepared by drying chloroform
solutions of the lipids under a stream of nitrogen gas followed by desiccation under
vacuum. The resulting dried lipid film was then rehydrated in buffer, subjected to
3–5 freeze-thaw cycles, and sonicated until the solution becomes clear. SUVs
composed of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-
dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), and 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) at a ratio 5:3:2 w/w, respectively, were prepared (this lipid
composition has been previously proposed to be a good model that mimics the
physiological lipid membrane composition53). Two percent of paramagnetic lipid
with an unpaired electron located at the hydrophilic head group (1,2-dimyristoyl-
sn-glycero-3-phosphoethanolamine-N-DTPA gadolinium salt), or at carbon 16 of
the lipid tail (1-palmitoyl-2-stearoyl-[16-doxyl]-sn-glycero-3-phosphocholine)
were added to the lipid mixture, to probe the interaction of the protein with the
surface of the membrane or the interior of the membrane, respectively. The protein
sample was incubated with SUVs for 1 h before pelleting down using a TLA-120.2
Beckman rotor (Beckman Coulter UK Ltd., High Wycombe, UK, 30 min,
300,000 × g). The resulting pellet was transferred into 3.2 mm Zirconia XC thin-
walled MAS rotors for ssNMR experiments.
Interaction of αS species with SUVs using far-UV CD. To investigate the
interaction of αS in the different aggregated states with lipid membranes, we
monitored the change in the mean residue ellipticity of αS at 222 nm at increasing
lipid:αS molar ratios using SUVS of 5:3:2 of DOPE:DOPS:DOPC. The different αS
species (10 μM mass concentration) were incubated with SUVs at varying con-
centrations for at least 1 h at room temperature prior to measurement, and
membrane binding affinity was estimated according to the binding equation
derived by assuming a fixed but unknown number of lipid molecules interacting
with one molecule of protein with identical affinity54.
Calcein release in SUVs. The kinetics of lipid membrane permeabilisation
induced by the different αS species was obtained by monitoring the increase in
fluorescence due to the leakage of entrapped calcein within SUVs (5:3:2 of DOPE:
DOPS:DOPC) over time4. The different protein species (0.05 μM) were added to
SUVs (5 μM) and the fluorescence measurements were obtained using a Varian
Cary Eclipse fluorimeter (Palo Alto) at 20 °C in a 2 mm × 10 mm path length
cuvette using excitation and emission wavelengths of 485 and 520 nm, respectively.








where F is the fluorescence measured in the presence of the different αS species,
Fcontrol is the fluorescence measured of the SUVs alone, and Ftot is the total
fluorescence obtained after complete disruption of SUVs using Triton X-100
(1% v/v).
AFM. All images were acquired at room temperature in air typically using inter-
mittent contact mode on a Nanowizard II atomic force microscope (JPK Instru-
ments, Berlin, Germany) except for the analysis of OA* and OB* samples, which
were acquired using tapping mode in a Multimode 8 atomic force microscope
(Bruker, Massachusetts, USA). The different αS species (0.1–1 μM, 10 μL) were
applied onto a layer of freshly cleaved mica and allowed to air-dry. The samples
were washed with water to remove any salts and dried again before imaging.
Images were processed and analyzed with Gwyddion open source software (version
2.48) (http://www.gwyddion.net).
Far-UV CD. Far-UV CD spectra of the different αS species were acquired in PBS at
20 °C between 200 and 250 nm, using a scan speed of 50 nmmin−1 and a band-
width of 1 nm. Ten accumulations were recorded for each sample, using a 1-mm
path length cuvette and a J-810 Jasco spectropolarimeter (Tokyo, Japan), equipped
with a thermostated cell holder.
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FT-IR. FT-IR spectra of the different αS species (100–400 μM) were acquired in
PBS and analyzed in a Bruker BioATRCell II using a Bruker Equinox 55 FT-IR
spectrophotometer (Bruker Optics Limited, UK) equipped with a liquid-nitrogen-
cooled mercury cadmium telluride (MCT) detector and a silicon internal reflection
element (IRE). For each spectrum, 256 interferograms were recorded at 2 cm–1
resolution. Data processing of the amide I region (1720–1580 cm−1) was per-
formed with the Opus software package (Bruker Optics Limited, UK) and consisted
of a background subtraction of the buffer spectra, atmospheric compensation, and
baseline subtraction. All absorbance spectra were normalized for comparison.
X-ray diffraction. Protein stalks were prepared by air drying 10 μL of ~800 μM
(mass concentration) of the different αS species between two wax-filled capillary
ends mounted in a Petri dish55. X-rays were generated using MICROSTAR
microfocus rotating anode X-ray generator and the diffraction data were collected
on a X8 Proteum system (Bruker AXS). The data were subsequently analyzed on
PROTEUM 2 software suite.
ThT and ANS fluorescence. Fluorescence measurements were performed in a
2 mm × 10 mm path length cuvette, using a Varian Cary Eclipse fluorimeter (Palo
Alto, CA, USA) in a temperature-controlled cell holder. ThT fluorescence was
monitored by exciting the sample at 446 nm and recording the emission fluores-
cence spectrum between 460 and 600 nm (5-nm slitwidths). Each protein species
(10 μM) was incubated with ThT (50 μM, ε416nm= 26,620M−1 cm−1) in PBS for
30 min before performing the measurement. ANS binding was monitored by
exciting the sample at 350 nm and recording the emission spectrum between 400
and 650 nm (5-nm slitwidths). Each protein species (5 μM) was incubated with
ANS (250 μM, ε350nm= 5000M−1 cm−1) in PBS for 30 min before recording the
spectra.
Cell cultures. Authenticated human neuroblastoma SH-SY5Y cells were purchased
from A.T.C.C. (Manassas, VA, USA). SH-SY5Y cells were tested negative for
mycoplasma contaminations, and were maintained in a 5% CO2 humidified
atmosphere at 37 °C and grown until 80% confluence for a maximum of 20
passages12,37.
Primary cortical neurons were obtained from embryonic day (ED)-17 Sprague-
Dawley rats (Harlan)56, maintained in neuronal basal medium (NBM) at 37 °C in a
5.0% CO2-humidified atmosphere and analyzed 14 days after plating8,12.
Experiments and animal use procedures were in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH
Publications No. 80-23, revised 1996). The experimental protocols were approved
by the “Commissione per l’Etica della ricerca” of the University of Florence, in
compliance with the European Convention for the Protection of Vertebrate
Animals used for Experimental and Other Scientific Purposes (ETS no. 123) and
the European Communities Council Directive of 24 November 1986 (86/609/EEC).
The authors further attest that all efforts were made to minimize the number of
animals used and their suffering.
Human iPSC-derived dopaminergic neurons were purchased from Axol
Bioscience (Cambridge, UK), which obtains human cell resources from cell
repositories who guarantee all human cell collections are performed at certified
facilities under the highest ethical standards. Discrete legal consent form was
obtained and the donors’ or clinics’ rights to hold research uses, for any purpose, or
further commercialization use were waved. All human cells were collected under
protocols that are in compliance with the Health Insurance Portability and
Accountability Act of 1996 (HIPAA). Human iPSC-derived dopaminergic neuron
progenitors were plated and led to maturation according to manufacturer’s
instructions. In detail, they were plated on 12-well plates containing glass coverslips
coated with poly-D-lysine plus surebond-XF solution. Then the maturation to
dopaminergic neurons was achieved starting from day 1, by growing the cells in
differentiation medium at 37 °C with 5% CO2. On day 5 post-plating, the
differentiation medium was replaced with the maintenance medium, which was
changed every 2 days. The resulting iPSC-derived dopaminergic neurons were
characterized and analyzed between day 14 and day 18 of culturing. The cells were
fixed in 4% (v/v) paraformaldehyde at room temperature and blocked with fetal
bovine serum in 0.1% Triton X-100 for 30 min. Coverslips were incubated with
1:300 diluted rabbit anti-MAP-2 antibodies (ab32454, Abcam) and 1:200 diluted
mouse anti-TH antibodies (sc-25269, Santa Cruz Biotechnology) in blocking
solution overnight at 4 °C. After washing with PBS, the cells were incubated with
1:500 diluted Alexa-Fluor-568-conjugated anti-rabbit secondary antibodies
(Thermo Fisher Scientific) and 1:500 diluted Alexa-Fluor-514-conjugated anti-
mouse secondary antibodies (Thermo Fisher Scientific) for 90 min at room
temperature. Finally, coverslips were incubated in PBS containing DAPI for 15 min
at room temperature. Fluorescence emission was detected after double excitation at
568 and 514 nm by a TCS SP8 scanning confocal microscopy system (Leica
Microsystems, Mannheim, Germany).
Confocal microscopy analysis for the penetration of αS species. αS species
were added to the cell CM of SH-SY5Y cells seeded on glass coverslips typically for
1 h at 0.3 μM. In a set of experiments, OB*, SF, or LF were added to the cell CM of
SH-SY5Y cells seeded on glass coverslips for different lengths of time (0, 1, 3, 6, and
24 h). In another set of experiments, SH-SY5Y cells were treated for 6 h at 37 °C
and then with or without 0.05% trypsin for 15 min at 4 °C. In an additional
experiment, SH-SY5Y cells were treated for 6 h at 37 °C with or without 5 µM
dynamin inhibitor I, dynasore (Sigma-Aldrich, St. Louis, MO, USA) or for 6 h at
4 °C. Following membrane permeabilization, αS was detected with 1:250 diluted
rabbit polyclonal anti-αS antibodies (ab52168 Abcam, Cambridge, UK) and with
1:1000 diluted Alexa-Fluor-488-conjugated anti-rabbit secondary antibodies
(Thermo Fisher Scientific). In another set of experiments, OB* and SF were added
to the CM of SH-SY5Y cells seeded on glass coverslips for 1 h at increasing con-
centrations (0.03, 0.1, 0.3, 1.0, and 3.0 μM) and the immunostaining analysis was
performed as described below.
In a set of experiments, OB*, SF, and LF at 0.3 μM were added to the CM of
iPSC-derived dopaminergic neurons for 24 h. The cells were fixed in 4% (v/v)
paraformaldehyde at room temperature and blocked with fetal bovine serum in
0.1% Triton X-100 for 30 min Coverslips were incubated with 1:400 diluted mouse
anti-MAP-2 antibodies (ab11267, Abcam) and 1:250 diluted rabbit anti-oligomer
A11 polyclonal antibodies (AHB0052 Thermo Fisher Scientific) in blocking
solution overnight at 4 °C. After washing with PBS, the cells were incubated with
1:500 diluted Alexa-Fluor-568-conjugated anti-rabbit secondary antibodies
(Thermo Fisher Scientific) and 1:500 diluted Alexa-Fluor-514-conjugated anti-
mouse secondary antibodies (Thermo Fisher Scientific) for 90 min at room
temperature.
In another set of experiments, OB*, SF, and LF at 0.3 μM were added to the CM
of SH-SY5Y cells for different lengths of time (0, 3, 6, 14, and 24 h). Following
membrane permeabilization, αS was detected with 1:250 diluted rabbit anti-
oligomer A11 polyclonal antibodies (AHB0052 Thermo Fisher Scientific), and with
1:1000 diluted Alexa-Fluor-488-conjugated anti-rabbit secondary antibodies (A-
11034 Thermo Fisher Scientific). In another set of experiments, OB* and SF were
added to the CM of SH-SY5Y cells at 0.3 µM for different lengths of time (0, 3, 6,
14, and 24 h). Following membrane permeabilization, αS was detected with 1:300
diluted rabbit oligomer-specific Syn33 polyclonal antibodies (ABN2265M, Sigma-
Aldrich) and then with 1:1000 diluted Alexa-Fluor-488-conjugated anti-rabbit
secondary antibodies (A-11034 Thermo Fisher Scientific).
In another set of experiments, OB* were added to the CM of SH-SY5Y cells at
different concentrations (0.03, 0.1, 0.3, 1, and 3 µM) for 1 h. αS was detected with
1:250 diluted rabbit anti-oligomer A11 polyclonal antibodies (AHB0052 Thermo
Fisher Scientific), and with 1:1000 diluted Alexa-Fluor-488-conjugated anti-rabbit
secondary antibodies (A-11034 Thermo Fisher Scientific). In another set of
experiments, OB*, SF, and LF at 0.3 μM were added to the CM for 30 min and then
polyclonal A11 (AHB0052 Thermo Fisher Scientific) or OC (AB2286 Sigma-
Aldrich) conformation-sensitive antibodies were added for 24 h to the extracellular
medium (in a molar ratio of 1:2.5). The cells were then counterstained with 5.0 μg/
ml Alexa-Fluor 633-conjugated WGA (W21404 Thermo Fisher Scientific)57 fixed
with 2% (v/v) paraformaldehyde, permeabilized and αS was detected with 1:250
diluted rabbit polyclonal anti-αS antibodies (ab52168 Abcam) and with 1:1000
diluted Alexa-Fluor-488-conjugated anti-rabbit secondary antibodies (A-11034
Thermo Fisher Scientific). Fluorescence emission was detected after double
excitation at 633 and 488 nm by the TCS SP8 scanning confocal microscopy system
(Leica Microsystems, Mannheim, Germany) equipped with an argon laser source.
A series of 1.0-μm-thick optical sections (1024 × 1024 pixels) was taken through
the cell depth for each sample using a Leica Plan Apo ×63 oil immersion objective
and projected as a single composite image by superimposition. In some
experiments, four optical sections near the coverslip were merged to a single
composite image, which we referred to as basal planes, four optical sections more
distant from the coverslip were merged and referred to as median planes and four
higher top optical sections were merged and referred to as apical planes. The
confocal microscope was set at optimal acquisition conditions, e.g., pinhole
diameters, detector gain, and laser powers. Settings were maintained constant for
each analysis.
Measurement of intracellular ROS and mitochondrial superoxide ions. αS
species were added to the CM of SH-SY5Y cells seeded on glass coverslips for
15 min at various concentrations (0.03, 0.1, 0.3, 1.0, and 3.0 μM). In a set of
experiments, 0.3 µM OB* were added to the CM for different lengths of time (0, 5,
10, 15, 30, and 60 min). In a set of experiments, LPS-free αS species (M, OB*, and
LF) were compared to normal samples, by adding them to the CM of SH-SY5Y
cells seeded on glass coverslips for 15 min at 0.3 μM. We used this time the CM-
H2DCFDA probe to detect and quantify intracellular levels of hydrogen peroxide as
a ROS marker, although we reported similar results for the OB* when the intra-
cellular accumulation of ROS was followed by Hyper-3 (probe for hydrogen per-
oxide) and dihydroethidium (probe for superoxide radical) in primary neuronal
cells39. In order to quantify hydrogen peroxide, then, cells were loaded with 5 μM
2′,7′-dichlorodihydrofluorescein diacetate for 10 min (CM-H2DCFDA, Thermo
Fisher Scientific)8,45. The emitted fluorescence was detected at 488 nm excitation
line by the confocal scanning system described above.
Mitochondrial superoxide ion production was detected with a static time-point
measurement in living SH-SY5Y cells with MitoSOX probe (Thermo Fisher
Scientific). Fluorescently labeled AF488-OB* and AF488-SF were added to the CM
of SH-SY5Y cells for 1 h at 0.03, 0.1, and 0.3 µM, and the red and green emitted
fluorescences were detected at 550 and 488 nm excitation lines, respectively, by the
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confocal scanning system described above. As a positive control, cells were also
treated with 250 µM H2O2 and the analysis was performed as described above.
Alteration of membrane permeability. The membrane integrity disruption was
assessed in SH-SY5Y cells and primary rat cortical neurons seeded on glass
coverslips57. Briefly, cells were loaded with 1.0 μM calcein-AM (Thermo Fisher
Scientific) for 10 min at 37 °C and then treated for 1 h with αS species at 0.3 μM. In
another set of experiments, 0.3 µM OB* were added to the CM of SH-SY5Y cells
for different lengths of time (0, 5, 10, 15, 30, and 60 min). The membrane integrity
disruption was also assessed in SH-SY5Y cells treated for 1 h with αS species (M,
OA*, and OB*) derived from N-acetylated αS protein at 0.3 μM. The emitted
fluorescence was detected at 488 nm excitation line by the confocal scanning sys-
tem described above.
Measurement of intracellular Ca2+. αS species were added to the CM of SH-
SY5Y cells and primary rat cortical neurons seeded on glass coverslips for 15 min at
various concentrations (0.03, 0.1, 0.3, 1.0, and 3.0 μM). In a set of experiments,
0.3 µM OB* were added to the CM of SH-SY5Y cells for 0, 5, 10, 15, 30, 60, and
180 min and to primary rat cortical neurons for 0, 5, 15, 60, and 180 min. Cells
were also treated with 0.3 µM OB* in CM without Ca2+. In a set of experiments,
cells were treated for 15 or 180 min with 0.3 µM M in the absence or presence of
0.03 µM SF (monomers equivalents, corresponding to 10% of monomers). Then
the cells were loaded with 10 μM Fluo-4 AM (Thermo Fisher Scientific) and the
analysis was performed by confocal microscopy (excitation at 488 nm)37,57.
In a set of experiments, the Ca2+ influx was analyzed in real-time in living SH-
SY5Y cells loaded with the Fluo-4 AM probe for 10 min. The intracellular Ca2+
basal level in living cells was measured for 10 min and then Ca2+ currents were
analyzed following the addition of OB* or SF up to 30 min. The emitted
fluorescence was detected at 488 nm excitation line over time by the confocal
scanning system described above.
Measurement of caspase-3 activity. OB*/SF/LF were added to the CM of iPSC-
derived dopaminergic neurons seeded on glass coverslips for 24 h at 0.3 μM. In
another set of experiments, SH-SY5Y cells seeded on glass coverslips were treated
with M/OA/OB*/SF/LF for 24 h at 0.3 μM or for different lengths of time (0, 1, 3, 5,
and 24 h). After incubation, the CM was removed and replaced for 1 h with the
FAM-FLICA Caspase-3/7 solution (Immunochemistry Technologies, LLC, Bloo-
mington, MN). The FLICA reagent FAM-DEVD-FMK enters each cell and binds
irreversibly and covalently to active caspase-3. The reagent bound covalently to the
active enzymes is retained in the cell, while the unbound reagent diffuses outside
and is washed away. The emitted fluorescence was then detected at 488-nm
excitation by the confocal scanning system described above.
MTT reduction assay. The cytotoxicity of αS species was assessed on SH-SY5Y
cells and primary rat cortical neurons seeded in 96-well plates, 24 h after their
addition to the CM at various concentrations (0.03, 0.3, and 3.0 μM), by the MTT
assay37,58. SH-SY5Y cells were treated for 24 h with αS species (M, OA*, and OB*)
derived from N-acetylated αS protein at 0.3 μM. In a set of experiments, LPS-free
αS species (M, OB*, and LF) were compared to normal samples, by adding them to
the CM of SH-SY5Y cells seeded on glass coverslips for 24 h at 0.3 μM. In a set of
experiments, αS species were added to the CM of SH-SY5Y cells at 0.3 μM for
different lengths of time (0, 1, 3, 5, and 24 h) and the MTT assay was assessed. In
another set of experiments, OB*, SF, and LF at 0.3 μM were added to the CM of
SH-SY5Y cells and, following 30 min of treatment, A11 or OC antibodies (in a
molar ratio of 1:2.5) (AHB0052 Thermo Fisher Scientific and AB2286 Sigma-
Aldrich, respectively), were added to the extracellular medium for 24 h and the
MTT assay was assessed. A11 and OC antibodies alone were also analyzed as
control. After treatment, the CM was removed, cells were washed with PBS and the
MTT solution was added to the cells for 4 h. The formazan product was solubilized
with cell lysis buffer (20% sodium dodecyl sulfate (SDS), 50% N, N-dimethylfor-
mamide, pH 4.7) for 1 h. The absorbance values of blue formazan were determined
at 590 nm. MTT tests were achieved using Microplate Manager® Software (Biorad,
CA, USA). Cell viability was expressed as the percentage of MTT reduction in
treated cells as compared to those untreated.
Dot-blot analysis. Dot-blot analyses of αS species (OA, OB*, SF, and LF) were
performed by spotting 2.0 µl (0.36mg/ml) of each conformer onto a 0.2 µm nitro-
cellulose membrane. After blocking (1.0% bovine serum albumin in TBS/TWEEN
0.1%) the blots were probed with 1:1200 diluted rabbit anti-oligomer A11 polyclonal
antibodies (AHB0052, Thermo Fisher Scientific), or with 1:1000 rabbit anti-amyloid
fibrils OC (AB2286, Sigma-Aldrich) or with 1:1250 diluted conformation-insensitive
rabbit polyclonal anti-αS antibodies (ab52168 Abcam) or with 1:250 diluted
conformation-insensitive mouse monoclonal 211 anti-αS antibodies (sc12767, Santa
Cruz Biotechnology). In a set of experiments, αS species (OB*, SF, and LF) spotted
onto the nitrocellulose membrane were detected with 1:3000 diluted rabbit oligomer-
specific Syn33 antibody (ABN2265M, Sigma-Aldrich). Then, the blots were incubated
with 1:3000 diluted HRP-conjugated anti-rabbit or anti-mouse secondary antibodies
(AB6721 and AB6728, Abcam). The immunolabeled bands were detected using a
SuperSignalWest Dura (Pierce, Rockford, IL, USA) and ImageQuant™ TL software (GE
Healthcare UK Limited version 8.2).
Confocal microscopy analysis of αS species in the absence of cells in vitro. SF
and LF at 0.3 μM were incubated in CM without cells in wells containing a glass
coverslip for 0, 1, 3, and 24 h at 37 °C. Following the incubation, the coverslips were
fixed with 2% (v/v) paraformaldehyde, incubated with BSA 0.5% to avoid unspe-
cific adherence of antibodies to the glass coverslip, and finally incubated for 30 min
at 37 °C with 1:2000 diluted mouse monoclonal 211 anti-αS IgG1 antibodies
(sc12767, Santa Cruz Biotechnology) or with 1:2500 diluted rabbit anti-oligomer
A11 polyclonal antibodies (Thermo Fisher Scientific), and then for 30 min with
1:2000 Alexa-Fluor 514-conjugated anti-mouse or anti-rabbit secondary antibodies
(Thermo Fisher Scientific). The emitted fluorescence was detected at 514-nm
excitation line by the confocal scanning system described above. The analysis was
also performed with OB* at 0 and 24 h as positive control, and with primary and
secondary antibodies without αS, to exclude any cross-reaction of the antibodies.
DLS. Size distribution analysis was performed with a Malvern ZetasizerNano S DLS
device (Malvern Panalytical, Malvern, United Kingdom) using SF at 1 µM in PBS
following incubation at 37 °C for different lengths of time (0, 3, 14, and 24 h). OB*
were also analyzed at 1 µM in PBS following incubation at 37 °C for 0 and 24 h.
Each sample was analyzed considering the refraction index and viscosity of its
dispersant. A 45-mm reduced volume plastic cell was used.
Analysis of the kinetics of toxicity using the different cellular readouts. The
different intracellular fluorescence intensities associated with Ca2+ influx and MTT
reduction were plotted versus the time elapsed after αS addition to the CM. A
variable number of cells were analyzed for every probe and time point and the
resulting kinetic plots were analyzed with a procedure of best-fitting using a single
exponential function of the form:
F tð Þ ¼ F eq þ A expðktÞ ð1Þ
where F(t) is the intracellular fluorescence at time t as a percentage of that observed
in untreated cells, F(eq) is the same fluorescence at the apparent equilibrium (time
∞), A is the amplitude of the exponential fluorescence change as a percentage of
that observed in untreated cells, and k is the apparent rate constant in s−1.
The intracellular fluorescence intensities associated with the intracellular αS
species recognized by A11 antibody were plotted versus the time elapsed after αS
addition to the CM and the resulting kinetic plots were analyzed with a procedure
of best-fitting using a sigmoidal function of the form
F tð Þ ¼ F eqð Þ þ F 0ð Þ  FðeqÞ
1þ ðktAÞB
where F(t) is the intracellular fluorescence at time t as a percentage of that observed
in untreated cells, F(0) is the same fluorescence at time zero, F(eq) is the same
fluorescence at the apparent equilibrium (time ∞), A is the amplitude of the
fluorescence change as a percentage of that observed in untreated cells, k is the
apparent rate constant in s−1, and B is the slope of the sigmoidal function at time t.
STED microscopy. STED xyz images (i.e., z-stacks acquired along three directions:
x, y, and z axes) of rat cortical neurons treated with OB* and SF at 0.3 µM for 14
and 24 h were acquired by using an SP8 STED 3X confocal microscope (Leica
Microsystems, Mannheim, Germany)37. Primary rat cortical neurons were coun-
terstained with 0.01 mg/ml WGA, Tetramethylrhodamine Conjugate (W849,
Thermo Fisher Scientific). αS was detected with 1:125 diluted conformation-
insensitive mouse monoclonal 211 anti-αS IgG1 antibodies (sc12767, Santa Cruz
Biotechnology) that recognize only the human protein, and 1:500 Alexa-Fluor 514-
goat anti-mouse IgG1 secondary antibody (A-31555, Thermo Fisher Scientific).
Fluoromount-G™ (00-4958-02, Fisher Scientific) was used as mounting medium.
Fluorescence emission was detected after double excitation at 550 and 514 nm.
STED xyz images were acquired in bidirectional mode with the Leica SP8 STED 3X
confocal microscope. Tetramethylrhodamine fluorophore was excited with a
550-nm-tuned white light laser (WLL) and emission collected from 564 to 599 nm,
Alexa-Fluor 514 was excited with a 510-nm-tuned WLL and emission collected
from 532 to 551 nm. Frame sequential acquisition was applied to avoid fluores-
cence overlap. It was applied a gating between 0.3 and 6 ns to avoid collection of
reflection and autofluorescence. Six-hundred-and-fifty-nanometer pulsed-
depletion laser was used for Alexa-Fluor 514 excitation. Images were acquired with
Leica HC PL APO CS2 100x/1.40 oil STED White objective. Gated pulsed-STED
were applied to Alexa-Fluor 514 fluorophore. Collected images were de-convolved
with Huygens Professional software (Scientific Volume Imaging B.V., Hilversum,
The Netherlands; version 18.04) and analyzed with Leica Application Suite X (LAS
X) software (Leica) to generate 3D reconstructions. Z-series stacks were obtained
from 5 μm neuron slices. Images were collected at 0.1-μm intervals.
In another experiment, SH-SY5Y cells were treated with fluorescently labeled
AF488-OB* and AF488-SF for 24 h and STED xyz images were acquired as
described above after double excitation at 550 and 488 nm.
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Measurements of the fluorescence intensities. To quantify the intensity of the
fluorescent signal arising from each probe, cells were analyzed by using the ImageJ
software (NIH, Bethesda, MD; version 1.52t). The fluorescence intensities were
measured in regions of interest, centered on single cells, whose dimensions
remained constant for all the analyzed images, and were then expressed as the ratio
(ΔF/F) of the change in fluorescence (ΔF) with respect to the resting baseline
fluorescence in untreated cells (F)57,59.
In immunofluorescence experiments, intracellular αS fluorescence intensity was
assessed in median planes by selecting multiple ROIs per cell in the cytoplasmic
compartment, excluding the cellular membrane, after background subtraction.
Similarly, the extracellular fluorescence was measured in basal, median, and apical
planes by selecting multiple ROIs per cell in the membrane compartment excluding
the cytoplasmic one, in order to include only the signals arising from the species
interacting with the outer leaflet of cell membranes. The fluorescence intensities
were then expressed as fractional changes above the resting baseline for untreated
cells (ΔF/F). In a set of experiments, the intracellular fluorescence was analyzed by
counting the number of puncta inside the cells, by using the ImageJ software. In
STED microscopy analyses, the fluorescence intensity arising from intracellular and
extracellular αS was expressed in arbitrary units, after background subtraction.
Comparison of the concentration of the fibrils. We estimated the same fibril
number concentrations for SF and LF (corresponding to a higher mass con-
centration for LF). For OB*, we took the average number of monomers per oli-
gomer from AUC analysis4. This was ca. 30 monomers. For the fibrils we can









where N is the number of monomers per aggregate, NA is the Avogadro’s constant,
MW is the molecular weight of the monomeric components, p is the density of the
aggregate (1.35 g/cm3), V is the volume of the fibril, and h and l are the height and
length of the fibril, respectively (derived from AFM). The numbers obtained are ca.
60 monomers for SFs and ca. 500 monomers for LFs.
Thus, 0.3 µM concentration (monomer equivalents) of SF and 3 µM
concentration (monomer equivalents) of LF give rise to ca. 0.005 µM particle
concentration in both samples.
Statistical analysis. All data were expressed as means ± standard error of mean (S.E.
M.). Comparisons between the different groups were performed by ANOVA followed
by Bonferroni’s post comparison test, by using GraphPad Prism 7.0 software.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data supporting the findings of this study are provided within the paper and its
supplementary information. A source data file is provided with this paper. All additional
information will be made available upon reasonable request to the authors. The data
reported in Fig. 1a are deposited at the placeholder DOI link: https://doi.org/10.17863/
CAM.59871. Source data are provided with this paper.
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